What is PGT-A done with?

PGT-A means preimplantation genetic testing for aneuploidy. It is performed as part of an IVF cycle. After an embryo reaches a suitable stage, a trained laboratory team removes a small group of cells from its outer layer. The embryo is usually frozen while the sample is analysed.

The sample is examined for extra or missing chromosomes. Next-generation sequencing can read genetic material from the sample and help the laboratory classify chromosome findings. PGT-A does not examine every cell in the embryo, and a result cannot predict every aspect of a future pregnancy or a child's health.

Ask the fertility team whether PGT-A addresses your particular situation and how the result could change embryo selection or transfer planning. Confirm how embryos and biopsy samples are labelled, when results are expected, and whether genetic counselling is available.

A result may be reported using categories such as an embryo with a chromosome finding, no detected finding of the type tested, or an uncertain or mixed result. Your team should explain what the laboratory wording means before you make a decision about transfer.

Contact the fertility clinic urgently for severe pain, heavy bleeding, faintness, breathing difficulty, or rapidly increasing abdominal swelling after egg collection or another IVF procedure. These symptoms relate to the treatment cycle and need prompt assessment, rather than being signs that a PGT-A result is accurate or inaccurate.

Why might PGT-A help in my circumstances? How are the embryo biopsy and sample analysed? What do each possible result and a mixed result mean, and how will those findings affect transfer choices or counselling?